NEUROGT INC

Creating futures through transformative science and sustainable vision.

NEUROGT INC was founded in 2020, is headquartered in Durham, United States, lists 1–10 employees, and has $1.3M in recorded funding across 3 rounds.

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$1.3M
Last Round
$307K GrantAug 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

NeuroGT is a clinical-stage gene therapy company targeting rare neurogenetic diseases affecting the central nervous system and metabolic pathways. Its platform includes AAV9 gene replacement therapy, Antibody Cleaver (AbC) technology for enabling re-dosing, and AAV-mediated extracellular vesicle mRNA delivery. The company focuses on lysosomal storage disorders including Hurler, Hunter, and Sanfilippo syndromes.

Summary

NEUROGT INC is a Biotech company based in Durham, United States, founded in 2020. It lists 1–10 employees. It has raised $1.3M in total across 3 rounds, most recently a $307K Grant round in Aug 2023. Investors include National Institutes of Health and National Institute of Allergy and Infectious Diseases.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantAug 2023
$307K

Sign up to see all 3 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NEUROGT INC on Indexed.vc
<a href="https://indexed.vc/companies/neurogt-inc"><img src="https://indexed.vc/api/badge/company/neurogt-inc" alt="NEUROGT INC on Indexed.vc" width="260" height="76" /></a>